Literature DB >> 21959785

Therapeutic plasma concentrations of antidepressants and antipsychotics: lessons from PET imaging.

G Gründer1, C Hiemke, M Paulzen, T Veselinovic, I Vernaleken.   

Abstract

Therapeutic Drug Monitoring (TDM) of psychotropic drugs is strongly depending on the validity of recommended therapeutic plasma concentration reference ranges. Rational pharmacotherapy is based on the assumption that plasma concentrations are directly related to target occupancy by the respective drug. Here we show that positron emission tomography (PET) of molecular drug targets in the brain (neuroreceptors and transporters) allows for establishment of these relationships, thereby providing guidance for TDM services. Associations between brain target occupancy, plasma concentrations, and clinical effects and adverse reactions will be discussed for the most commonly used antidepressant and antipsychotic drugs. Georg Thieme Verlag KG Stuttgart · New York.

Mesh:

Substances:

Year:  2011        PMID: 21959785     DOI: 10.1055/s-0031-1286282

Source DB:  PubMed          Journal:  Pharmacopsychiatry        ISSN: 0176-3679            Impact factor:   5.788


  12 in total

1.  Flupentixol: relevance of stereoselective therapeutic drug monitoring.

Authors:  Pierre Baumann; Hartmut Kirchherr; Patricia Berney; Christoph Hiemke
Journal:  Psychopharmacology (Berl)       Date:  2012-04-04       Impact factor: 4.530

Review 2.  Neuropeptide receptor ligands as drugs for psychiatric diseases: the end of the beginning?

Authors:  Guy Griebel; Florian Holsboer
Journal:  Nat Rev Drug Discov       Date:  2012-05-18       Impact factor: 84.694

Review 3.  [Therapeutic drug monitoring in psychiatry. A brief summary of the new consensus paper by the task force on TDM of the AGNP].

Authors:  G Gründer; P Baumann; A Conca; G Zernig; C Hiemke
Journal:  Nervenarzt       Date:  2014-07       Impact factor: 1.214

4.  Inflammation and psychotropic drugs: the relationship between C-reactive protein and antipsychotic drug levels.

Authors:  Gudrun Hefner; Mohamed E E Shams; Stefan Unterecker; Tanja Falter; Christoph Hiemke
Journal:  Psychopharmacology (Berl)       Date:  2015-06-03       Impact factor: 4.530

5.  Current use of anticholinergic medications in a large naturalistic sample of psychiatric patients.

Authors:  Sermin Toto; Gudrun Hefner; Martina Hahn; Christoph Hiemke; Sibylle C Roll; Jan Wolff; Ansgar Klimke
Journal:  J Neural Transm (Vienna)       Date:  2021-01-13       Impact factor: 3.575

6.  Flupentixol use and adverse reactions in comparison with other common first- and second-generation antipsychotics: data from the AMSP study.

Authors:  R Grohmann; R R Engel; H-J Möller; E Rüther; J W van der Velden; S Stübner
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-07-09       Impact factor: 5.270

7.  Dopamine D₂/₃ occupancy of ziprasidone across a day: a within-subject PET study.

Authors:  Takefumi Suzuki; Ariel Graff-Guerrero; Hiroyuki Uchida; Gary Remington; Fernando Caravaggio; Carol Borlido; Bruce Pollock; Benoit Mulsant; Vincenzo Deluca; Zahinoor Ismail; David Mamo
Journal:  Psychopharmacology (Berl)       Date:  2013-02-17       Impact factor: 4.530

8.  Effects of gender and age on serum concentrations of antidepressants under naturalistic conditions.

Authors:  S Unterecker; P Riederer; F Proft; J Maloney; J Deckert; B Pfuhlmann
Journal:  J Neural Transm (Vienna)       Date:  2012-12-20       Impact factor: 3.575

9.  Prevalence of Therapeutic Drug Monitoring for Antidepressants and Antipsychotics in Stockholm, Sweden: A Longitudinal Analysis.

Authors:  Susanna M Wallerstedt; Jonatan D Lindh
Journal:  Ther Drug Monit       Date:  2015-08       Impact factor: 3.681

10.  Effect of CYP2D6 polymorphisms on plasma concentration and therapeutic effect of risperidone.

Authors:  Jinjun Lu; Ye Yang; Jian Lu; Zuqing Wang; Yiping He; Yeliang Yan; Kai Fu; Wenjuan Jiang; Yunqing Xu; Renrong Wu; Wenqing Liu; Jingping Zhao
Journal:  BMC Psychiatry       Date:  2021-02-03       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.